Ozonized Gel vs Gaseous Ozone Against S. Mutans in Deciduos Molars Caries

April 15, 2025 updated by: Andrea Scribante, University of Pavia

Ozonized Gel vs Gaseous Ozone Against S. Mutans in Deciduos Molars Caries: Randomized Clinical Trial

The aim of this study is to verify, through bacteriological analysis, the efficacy of reducing the bacterial load referred to the presence of Streptococcus Mutans in carious lesions of viable deciduous molars by application of gaseous ozone or ozonized gel.

Patients who meet the eligibility criteria and for whom the legal guardians have signed the informed consent, will undergo treatment of the carious lesion with gaseous ozone or ozonized gel. After selective removal of dentin, a bacterial sample will be taken from the carious surface with a sterile paper cone at time T0; then ozone will be applied for 30 seconds, the surface will be washed with sterile saline and dried with air, a second sample will be taken at time T2; finally, ozone will be applied for another 30 seconds, the surface will be washed with sterile saline and dried with air, a third sample will be taken at time T2.

Patients are then randomised into two groups:

Test group: gaseous ozone (Healozone X4) is applied to the carious lesion for 30 seconds and then for another 30 seconds.

Control group: ozone gel (GeliO3) will be applied to the carious lesion for 30 seconds and then for another 30 seconds.

Changes in the following indices will be assessed at the first visit and when the samples are taken at T0, T1, T2: compliance assessment (FLACC scale), sensitivity test (Schiff Air Index), assessment of lesion severity and extent (ICDAS), assessment of gingival inflammation (GI), assessment of plaque index (PI), assessment of severity of enamel erosion (Bewe index).

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lombardy
      • Pavia, Lombardy, Italy, 27100
        • Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients suffering from carious lesion on viable deciduous molar
  • patients' compliance

Exclusion Criteria:

  • patients with early loss of deciduous molars for carious lesions or orthodontic reasons
  • non-viable deciduous molars
  • deciduous molars with traumatic lesions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ozone gel group
Administration of Ozonized Gel GeliO3
Active Comparator: Gaseous ozone group
Admininstration of Gaseous ozone (Healozone X4)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in S. mutans counts
Time Frame: Baseline (T0), after 30 seconds (T1) and after 60 seconds (T2)
Evaluation of Colony forming units (CFU) of bacterials samples after treatment.
Baseline (T0), after 30 seconds (T1) and after 60 seconds (T2)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in FLACC
Time Frame: Baseline (T0), and after 60 seconds (T2)
The FLACC scale or Face, Legs, Activity, Cry, Consolability scale is a measurement used to assess pain for children with a score of 0 to 2 for each evaluation.
Baseline (T0), and after 60 seconds (T2)
Change in Schiff Air Index
Time Frame: Baseline (T0), and after 60 seconds (T2)

Scoring criteria:

0.= the subject does not respond to air stimulation;

  1. = the subject responds to stimulation with air but does not require interruption;
  2. = the subject responds to stimulation with air and requests interruption or moves away from the stimulus;
  3. = the subject responds to stimulation with air, considers the stimulus painful, requests its interruption or moves away from it.
Baseline (T0), and after 60 seconds (T2)
Gingival Index (calculated on Ramfjiord teeth)
Time Frame: Baseline (T0)

Scoring criteria:

0 = normal gingiva, no inflammation, no erythema, no bleeding

  1. = mild inflammation, slight erythema, minimal superficial alterations, no bleeding
  2. = moderate inflammation, erythema, bleeding on probing
  3. = severe inflammation, severe erythema and swellling, tendency to spontaneous bleeding, possible ulcers
Baseline (T0)
Plaque Index (calculated on Ramfjiord teeth)
Time Frame: Baseline (T0)

Scoring criteria:

0 = no plaque

  1. = thin layer of plaque at the gingival margin, detectable only by scraping with a probe
  2. = moderate layer of plaque along the gingival margin; free interdental spaces, but plaque is visible to the bare eye
  3. = abundant plaque along the gingival margin; plaque-filled interdental spaces.
Baseline (T0)
ICDAS
Time Frame: Baseline (T0)

Scoring criteria:

0 = healthy

  1. = White/brown stain in dry enamel
  2. = White/brown stain on wet enamel
  3. = Microcavity in dry enamel <0.5 mm with no visible dentin
  4. = Dark dentin shade seen through wet enamel with or without microcavity
  5. = Dentin exposure in the cavity> 0.5 mm in the middle of the dry tooth surface
  6. = Dentin exposure in cavity greater than half of the tooth surface
Baseline (T0)
Basic Erosive Wear Examination
Time Frame: Baseline (T0)

Scoring criteria:

0 = no tooth erosion

  1. = superficial enamel loss
  2. = hard tissue loss involving < 50% of tooth surface
  3. = hard tissue loss involving > 50% of tooth surface
Baseline (T0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea Scribante, DDS, PhD, University of Pavia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 21, 2024

Primary Completion (Actual)

April 1, 2025

Study Completion (Actual)

April 5, 2025

Study Registration Dates

First Submitted

October 11, 2024

First Submitted That Met QC Criteria

October 11, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

April 16, 2025

Last Update Submitted That Met QC Criteria

April 15, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-OZONECARIES

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will be available upon motivated request to the corresponding authors.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries

Clinical Trials on Ozonized gel

Subscribe